Вы находитесь на странице: 1из 34

Subscriber access provided by BUFFALO STATE

Article
Molecular Basis of Water Sorption Behavior
of Rivaroxaban-Malonic Acid Cocrystal
Dnyaneshwar P. Kale, Bharat Ugale, C. M. Nagaraja,
GURUDUTT DUBEY, Prasad V. Bharatam, and Arvind K Bansal
Mol. Pharmaceutics, Just Accepted Manuscript • DOI: 10.1021/
acs.molpharmaceut.9b00227 • Publication Date (Web): 03 Jun 2019
Downloaded from http://pubs.acs.org on June 5, 2019

Just Accepted

“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a service to the research community to expedite the dissemination
of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in
full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully
peer reviewed, but should not be considered the official version of record. They are citable by the
Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore,
the “Just Accepted” Web site may not include all articles that will be published in the journal. After
a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web
site and published as an ASAP article. Note that technical editing may introduce minor changes
to the manuscript text and/or graphics which could affect content, and all legal disclaimers and
ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or
consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W.,


Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the
course of their duties.
Page 1 of 33 Molecular Pharmaceutics

1
2
3
4
Molecular Basis of Water Sorption Behavior of Rivaroxaban-Malonic Acid
5
6
Cocrystal
7
8 Dnyaneshwar P. Kale,1 Bharat Ugale,2 C. M. Nagaraja,2 Gurudutt Dubey,3 Prasad V.
9
10 Bharatam,3 Arvind K. Bansal1 *
11
12
13 1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research
14
15 (NIPER), S.A.S. Nagar - 160 062, Punjab, India
16
17
18 2Department of Chemistry, Indian Institute of Technology (IIT) Ropar, Rupnagar - 140 001, Punjab,
19 India
20
21
3Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research
22
23 (NIPER), S.A.S. Nagar - 160 062, Punjab, India
24
25
26
27
28
29
30 *Corresponding author:
31
32 Arvind K. Bansal
33
34 Professor and Head, Department of Pharmaceutics
35
36 National Institute of Pharmaceutical Education and Research (NIPER),
37
38 S.A.S. Nagar, Mohali, Punjab- 160 062, India
39 Tel.: +91-172-2214682-2126; Fax: +91-172-2214692
40
41 Email address: akbansal@niper.ac.in
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

1
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 2 of 33

1
2
3 ABSTRACT
4
5
6
The present study aims to investigate the molecular basis of water sorption behavior of
7
8 rivaroxaban-malonic acid cocrystal (RIV-MAL). It was hypothesized that the amount of
9
10 water sorbed by a crystalline solid is governed by surface molecular environment of different
11
12
crystal facets, and their relative abundance to crystal surface. Water sorption behavior was
13
14
15 measured using dynamic vapor sorption analyzer. Surface molecular environment of different
16
17 crystal facets and their relative contribution were determined using single crystal structure
18
19 evaluation and face indexation analysis, respectively. The surface area normalized water
20
21
22 sorption for rivaroxaban (RIV), malonic acid (MAL) and RIV-MAL at 90% RH/25 °C was
23
24 0.28%, 92.6% and 11.1% w/w, respectively. The crystal surface of MAL had larger
25
26 contribution (58.7%) of hydrophilic (Hphi) functional groups, showed the ‘highest’ water
27
28
29
sorption (92.6% w/w). On the contrary, RIV had larger surface contribution (65.2%) of
30
31 hydrophobic (Hpho) functional groups and the smaller contribution (34.8%) of ‘Hphi+Hpho’
32
33 groups, exhibited the ‘lowest’ water sorption (0.28% w/w). The ‘intermediate’ water sorption
34
35
(11.1% w/w) by RIV-MAL as compared to RIV, was ascribed to the increased surface
36
37
38 contribution of ‘Hphi+Hpho’ groups (from 34.8% to 42.1%) and reduced hydrophobic
39
40 surface contribution (from 65.2% to 57.9%). However, the significantly higher water gained
41
42 (~39 fold) by the cocrystal as compared to RIV, despite the nominal change in the surface
43
44
45 contributions, was further attributed to the relatively stronger hydrogen bonding interactions
46
47 between the surface exposed carboxyl groups and water molecules. The study highlights that
48
49 the amount of water sorbed by the cocrystal is governed by the surface molecular
50
51
52
environment, and additionally by the strength of hydrogen bonding. This understanding has
53
54 implications on designing materials with desired moisture-sorption property.
55
56
57 Keywords: Hygroscopicity, Cocrystal, Face Indexing, Surface chemistry, Strength of
58
59 interactions
60

2
ACS Paragon Plus Environment
Page 3 of 33 Molecular Pharmaceutics

1
2
3 Table of Contents/ Abstract Graphic
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

3
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 4 of 33

1
2
3
4
INTRODUCTION
5
6 The term ‘hygroscopicity’ can be described as the amount of water vapor sorbed by a sample
7
8 when exposed to a known relative humidity (RH) at constant temperature.1, 2 Hygroscopicity
9
10 of materials is of paramount importance in pharmaceutical, fine chemical and food industries.
11
12
13 In pharmaceutical industry, it is well accepted that water content associated with drugs or
14
15 excipients in the solid state can have profound impact on variety of physicochemical
16
17 properties, such as physical and chemical stability3-5, dissolution6, flow properties and
18
19
compaction properties.7 Therefore, assessment of equilibrium water content of drug substance
20
21
22 and excipients has become integral part of preformulation activities, and is a parameter that
23
24 should be monitored during entire journey from discovery to drug product development.1, 2, 8,
25
26 9 Water sorption data is used as a guide in selecting a solid form of drug substance with better
27
28
29 RH stability and processability.1, 10
30
31
32 Modes of water sorption by solids are broadly divided into three categories: (1) adsorption, a
33
34 surface phenomenon involving the interaction between water molecules and surface of solid
35
36
without penetration into bulk phase, (2) absorption, which involves penetration of water
37
38
39 molecules into the bulk phase of solid, (3) liquefaction of water on surface of solid below
40
41 100% RH, which is caused due to either deliquescence or capillary condensation.11
42
43 Hygroscopicity of crystalline solids (crystalline salts, cocrystals, crystalline free
44
45
46 base/polymorphs) is mainly governed by adsorption while that of amorphous materials
47
48 (amorphous drug, co-amorphous systems, amorphous salts) by absorption process. However,
49
50 additionally, in crystalline solids, penetration of water into crystal lattice may lead to the
51
52
53
formation of stoichiometric or non-stoichiometric crystal hydrate, driven by solution-
54
55 mediated crystallization process.9
56
57
58 At a molecular level, the amount of water gained by a crystalline solid is mainly governed by
59
60 hydrogen bonding interactions between water molecules and functional groups that are
4
ACS Paragon Plus Environment
Page 5 of 33 Molecular Pharmaceutics

1
2
3 exposed on the crystal surface.2, 12Surface chemistry can vary significantly from facet to
4
5
6 facet, a phenomenon known as ‘surface anisotropy’.13-16 Surface anisotropy can be
7
8 understood by recognizing the 3D structure of molecules in a crystal, wherein the various
9
10 crystallographic planes corresponding to each crystal facet dissects (cut-up) the unit cell at
11
12
13
different planer orientations and angles. This exposes different chemical groups with varying
14
15 surface densities of those groups, resulting into varied surface chemical environments.13, 15 It
16
17 has been anticipated that the amount of water gained by a particular facet of crystal surface is
18
19
likely higher if hydrophilic functional groups are present, while the lesser amount of water
20
21
22 sorption is expected if hydrophobic (nonpolar or lipophilic) groups are exposed. This is
23
24 because, hydrophilic functional groups such as carboxyl (‒COOH), amino (‒NH2) or (‒OH)
25
26 favor hydrogen bonding interactions with water molecules (H‒O‒H). Accordingly, a total
27
28
29 amount of water sorbed by a crystal can be ascribed to the sum of hydrophilic contributions
30
31 from all crystal facets. Thus, it becomes important to find out the relative contribution
32
33 (relative abundance) of each facet and their affinity towards water molecules (hydrophilic or
34
35
36 hydrophobic). This approach of understanding the molecular mechanism of water sorption by
37
38 crystalline solids has not been experimentally validated for organic compounds.
39
40
41 Cocrystals are being increasingly utilized for modulating numerous physicochemical
42
43
properties including hygroscopicity. A number of studies have demonstrated the role of
44
45
46 cocrystals in alteration of hygroscopicity (moisture stability) of active pharmaceutical
47
48 ingredients (APIs) and excipients.17-25 Co-crystallization leads to a significant change in the
49
50 surface chemistry (surface molecular environment) of resultant crystalline solid because of
51
52
53 incorporation of two or more different compounds in the same crystal lattice and the altered
54
55 molecular arrangements. Understanding the relationship between hygroscopicity behavior of
56
57 cocrystals and their surface chemistry is a vital step in designing materials with desired water
58
59
60
sorption tendency. Therefore, the present study aims to understand the molecular basis of

5
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 6 of 33

1
2
3 water-sorption behavior of cocrystal using rivaroxaban: malonic acid cocrystal (RIV-MAL)
4
5
6 as a model system. Molecular basis of water sorption behavior was comprehended by
7
8 correlating the amount of water sorbed per unit surface area with the surface molecular
9
10 environment of rivaroxaban (RIV), malonic acid (MAL) and their cocrystal, RIV-MAL. It
11
12
13
was hypothesized that water-sorption behavior is governed by‒ (i) nature of crystal facets
14
15 (hydrophilic or hydrophobic or mixed) (ii) relative abundance (%contribution) of crystal
16
17 facets to total crystal surface and (iii) strength of interactions between exposed functional
18
19
groups and water molecules.
20
21
22
23 Dynamic vapor sorption (DVS) analysis was carried out to determine sorption-desorption
24
25 profile. Single crystal XRD was utilized to identify the exposed chemical groups on different
26
27 facets of a crystal, and face indexation analysis was used to measure % relative contributions
28
29
30
(relative abundance) of different facets onto crystal surface. Molecular lipophilic potential
31
32 (MLP) calculations of RIV and MAL were utilized to identify hydrophilic or hydrophobic
33
34 nature of functional groups. Strength of hydrogen bonding interactions was estimated using
35
36 Density Functional Theory (DFT) calculations. The surface molecular environment, in terms
37
38
39 of hydrophilic or hydrophobic nature of chemical groups and strength of hydrogen bond
40
41 formations, was correlated to the percentage of water sorption per unit surface area.
42
43
44 EXPERIMENTAL SECTION
45
46
Materials
47
48
49 RIV was received as a gift sample from Lupin Pharmaceuticals Ltd., India (Purity >99.5%).
50
51
52
MAL (Sigma-Aldrich, USA) and 2,2,2-trifluoroethanol (Spectrochem Pvt. Ltd, India) were
53
54 of analytical grade and used as received.
55
56
57
58
59
60

6
ACS Paragon Plus Environment
Page 7 of 33 Molecular Pharmaceutics

1
2
3 Crystallization Experiments
4
5
6 Crystallization experiments were performed to obtain good quality crystals for crystal
7
8
structure solution and face indexation studies. These crystalline samples were also employed
9
10
11 in DVS experiments so as to achieve minimal differences in their surface and morphological
12
13 characteristics.
14
15
16 RIV Crystals: RIV (25 mg) was dissolved in acetonitrile (10 mL) by heating in a water bath
17
18
19
at 60 °C for 5 min and cooled at room temperature (RT). The resultant solution was filtered
20
21 through a 0.2 µm pore size nylon membrane filter and kept in a 15 ml screw cap vial, which
22
23 was loosely capped to allow the slow solvent evaporation at RT. Columnar shaped crystals
24
25
26
were generated within a week.
27
28
29 MAL Crystals: MAL powder was dissolved in acetone at RT with continuous stirring till the
30
31 point of saturation. Single crystals were obtained after 5 to 7 days by slow evaporation of the
32
33 obtained solution.
34
35
36 RIV-MAL Crystals: RIV (87 mg) and MAL (60 mg) were dissolved in 2,2,2-trifluoroethanol
37
38
39 (1 mL) by heating in water bath at 75 to 80 °C to form a clear solution, and allowed to cool
40
41 first at 50 °C for 30 min and subsequently at RT. The resultant solution was kept in a 5 ml
42
43 loosely capped vial to allow slow evaporation of the solvent at RT. Single crystals appeared
44
45
46 within 1-2 weeks. The crystals were stored in the mother liquor to retain their morphological
47
48 and surface properties.
49
50
51 Differential Scanning Calorimetry (DSC)
52
53
54 Thermal analysis of the samples was performed using a Differential Scanning Calorimeter,
55
56 (model Q2000, TA Instruments, Delaware, USA) operating with TA Universal Analysis®
57
58
software, version 4.5A. About 2−4 mg of sample was weighed in Tzero aluminium pan,
59
60

7
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 8 of 33

1
2
3 crimped and subjected to thermal scanning at a heating rate of 10.0 °C/min. A dry nitrogen
4
5
6 purge was maintained at 50 mL/min. The instrument was calibrated for temperature and heat
7
8 flow using high purity standard indium prior to analysis.
9
10
11 Hot Stage Microscopy (HSM)
12
13
14 Thermally-induced physical changes in the crystal sample were observed under Leica DMLP
15
16 polarized microscope (Leica Microsystems Wetzlar GmbH, Wetzlar, Germany) equipped
17
18
19 with Linkam LTS 350 hot stage. The sample was mounted on a glass slide and subjected to
20
21 temperature from 30° to 240 °C at a heating rate of 10 °C/min. Photomicrographs were
22
23 acquired using JVS color video camera and analyzed using Linksys32 software.
24
25
26 X-ray Powder Diffractometry (XRPD)
27
28
29 XRPD patterns of the samples were recorded at room temperature using a parallel beam
30
31
geometry X-ray diffractometer (Rigaku Ultima IV diffractometer, Tokyo, Japan) equipped
32
33
34 with a Cu Kα source (1.54 Å), 2.5° primary and secondary solar slits, 0.5° divergence slit
35
36 with 10 mm height limit slit, sample rotation stage attachment and DTex Ulta detector. The
37
38
39
X-ray generator was operated at 40 kV and 40 mA power settings. Samples were mounted on
40
41 a poly(methyl methacrylate) (PMMA) sample holder and subjected to a continuous scan over
42
43 5−40° 2θ at a step size of 0.01° and a dwell time of 1 sec per step. The data were analyzed
44
45
with OriginPro software.
46
47
48
49
Attenuated Total Reflectance−Fourier Transform Infrared Spectroscopy (ATR-FTIR)
50
51 The IR spectra of cocrystal, RIV and MAL were recorded from scanning range of 4000 cm-1
52
53
54 to 650 cm-1 on an FTIR Spectrometer (Perkin Elmer Inc, Waltham, USA) equipped with
55
56 diamond/zinc selenide crystal attenuated total reflectance accessory. The data were analyzed
57
58 using Spectrum® software (Version 3.02.01).
59
60

8
ACS Paragon Plus Environment
Page 9 of 33 Molecular Pharmaceutics

1
2
3 Single-Crystal X-Ray Diffraction (SC-XRD) and Face indexing
4
5
6 Single crystal structure data of RIV and RIV-MAL were collected on a Bruker based D8
7
8
Venture diffractometer equipped with INCOATEC micro-focus source with graphite
9
10
11 monochromated Mo Kα radiation (λ = 0.71073 Å). A single crystal was selected and
12
13 mounted with paratone oil on a glass fiber of 0.2 mm diameter using gum, on the
14
15 diffractometer operating at 50 kV and 30 mA, which used a CMOS-PHOTON area detector
16
17
18 for determining unit cell parameters and orientation matrices at 295 K. Cell constants were
19
20 determined from reflections harvested from two sets of 12 frames. These initial sets of frames
21
22 were oriented such that orthogonal wedges of reciprocal space were surveyed. SAINT26
23
24
25
program was applied for data integration and SADABS27 program was used for absorption
26
27 correction. The structures were initially solved by SIR 9228 and refined using SHELXL-
28
29 201429 and WinGX system30, Ver 2013.3. All the non-hydrogen atoms were located from the
30
31
difference Fourier map and refined anisotropically and all the hydrogen atoms were fixed by
32
33
34 HFIX and included in the refinement process with isotropic thermal parameters and in few
35
36 cases with no constraints wherever required. Crystal information files (CIF) are deposited to
37
38 Cambridge Crystallographic Data Centre (CCDC), Cambridge, UK with the CCDC numbers
39
40
41 1854617 and 1854618 for RIV and RIV-MAL, respectively.
42
43 Face indexing was carried out to determine Miller indices of the different facets of a crystal.
44
45 Importantly, face indexation data help in determining the relative abundance (%
46
47
48
contributions) of each facet of a crystal surface. A series of photographs were taken with a
49
50 video microscope as the crystal is rotated through 360° about the ψ axis. Miller indices of
51
52 various facets of the crystal were identified using, the face indexing plug-in of APEX 2, also
53
54
known as T-tool.
55
56
57
58
59
60

9
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 10 of 33

1
2
3 Dynamic Vapor Sorption (DVS)
4
5
6 Hygroscopicity behavior (sorption-desorption profiles) of the samples were studied at 25 ±
7
8
0.1 °C using a DVS instrument (Q5000SA, TA Instruments, New Castle, Delaware, USA).
9
10
11 The crystals of RIV, MAL and RIV-MAL were used as samples for the present study. The
12
13 instrument was calibrated for humidity by taking the deliquescence point of sodium bromide
14
15 at 25 ± 0.1 °C to be 57.6 ± 1% RH as recommended by the manufacturer. Samples (15 ± 5
16
17
18 mg) were loaded onto a tared metal-coated quartz sample pan and an empty pan was used as
19
20 the reference. The sample was pre-dried at 25 °C/0% RH for 60 min and the instrument was
21
22 programmed for moisture sorption-desorption mode from 0 → 90 → 0% RH in 10% RH/step
23
24
25
and 5% RH/step from 90 → 95 → 90% RH. The equilibrium condition was set to <0.002%
26
27 of total mass change over 5 min or maximum dwell time of 2-4 h if the weight change criteria
28
29 could not meet. Each experiment was carried out in triplicate.
30
31
32 Molecular Dynamics Simulation Study
33
34
35 The purpose of molecular dynamics study was to identify hydrogen binding sites available in
36
37 the crystal structure of RIV, MAL, and RIV-MAL. This knowledge helps in determining the
38
39
40 accessible hydrogen bonding sites present on the different surfaces of the crystal. The
41
42 structure of RIV dimer, MAL dimer, and RIV-MAL (2:1) cocrystal from single crystal
43
44 solution were taken as a model for these studies. The molecular dynamics simulation was
45
46
47 performed using Desmond v3.2 program31 of Schrodinger software package using OPLS3
48
49 force field.32, 33 The solvent system was built for the simulation using a predefined water
50
51 model (TIP3P). The cubic shape box with dimensions 10Å × 10Å × 10Å was selected and
52
53
54
calculation methods were set to buffer. The simulation restraining of non solvent atoms was
55
56 performed by implementing Nose-Hoover chain thermostat method to maintain a constant
57
58 temperature of 298K and Martyna-Tobias-Klein barostat method to maintain a constant
59
60

10
ACS Paragon Plus Environment
Page 11 of 33 Molecular Pharmaceutics

1
2
3 pressure of 1.01325 bar under NPT ensemble. The relaxed system was simulated for 20ns
4
5
6 with the time step of 2fs and record interval of 1.2ps.
7
8
9 Determination of Molecular Lipophilic Potential (MLP)
10
11
12 Molecular lipophilic potential (MLP) analysis of RIV and MAL was carried out by selecting
13
14 the global range type using MOLCAD program available in SYBYL 7.1 molecular modeling
15
16 package. It provides lipophilic potential surrounding each atom or group of atoms. The nature
17
18
19
of functional groups (hydrophilic or hydrophobic) present in RIV and MAL was identified by
20
21 measuring MLP. Lower the value of lipophilic potential (represented as LP value) indicates
22
23 hydrophilic/polar groups, while the higher value of lipophilic potential indicates
24
25 hydrophobic/nonpolar groups.
26
27
28
29
Identifications of Surface Molecular Environment
30
31 The molecular packing corresponding to different crystallographic planes (Miller indices) for
32
33
34 RIV, MAL, and RIV-MAL was visualized using the respective CIF files in Mercury software
35
36 V3.7 (CCDC, UK). The visualization of molecular packing across different crystallographic
37
38 planes helped to precisely identify the chemical groups exposed onto a particular facet of the
39
40
41
crystal.
42
43
44 Density Functional Theory Calculation
45
46
The hydrogen bonding strength can be measured as a function of interaction energy. It can be
47
48
49 calculated by subtracting the total energy of the H-bond donor and acceptor from the energy
50
51 of H-bond donor-acceptor complex.34 Density Functional Theory (DFT) based quantum
52
53 chemical studies were performed to evaluate the strength of intermolecular hydrogen bonding
54
55
56 of RIV and MAL with water molecule(s). The geometry optimization was performed on
57
58 Gaussian09 suite software35 using B3LYP/6-31+G(d,p) level of theory.36 The absolute
59
60 energies of the geometries were taken into consideration for further calculation.
11
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 12 of 33

1
2
3 RESULTS AND DISCUSSION
4
5
6
Generation and Solid-State Characterization of RIV and RIV-MAL
7
8 Overlay of DSC heating curves and XRPD patterns of RIV, MAL and RIV-MAL are
9
10
11 presented in Figure 1. Columnar shaped RIV crystals were generated from acetonitrile by
12
13 slow solvent evaporation. DSC analysis of RIV showed a melting onset at 230.24 °C with a
14
15 heat of fusion (∆Hf) of 110.3 J/g, which corresponds to the melting temperature of
16
17
18
rivaroxaban form I (Figure 1a). XRPD pattern of RIV sample exhibited diffraction peaks at
19
20 2Ɵ values of 9.1°, 12.2°, 14.4°, 16.6°, 17.6°, 18.2°, 19.6°, 20.0°, 21.8°, 22.6°, 23.5°, 24.1°,
21
22 24.8°, 25.8°, 26.8°, 29.6°, 30.3°, 31.9° ± 0.2° (Figure 1b). The most intense diffraction peak
23
24
was observed at 2Ɵ value of 22.6° ± 0.2°. The diffraction peaks of the sample also
25
26
27 correspond to form I of RIV.37 Thick plate-shaped crystals of MAL were generated by slow
28
29 solvent evaporation of a saturated solution of MAL in acetone. The observed melting
30
31 temperature for MAL crystals was 134.6 °C (∆Hf ≈ 235 J/g), which relates to β form of
32
33
34 malonic acid.
35
36
37 Rectangular-shaped crystals of RIV-MAL were generated by slow solvent evaporation of
38
39 RIV and MAL solution, which was previously cooled in a step-wise manner. The step-wise
40
41 cooling of the hot solution, as described in the method section, was critical for the successful
42
43
44 generation of crystals suitable for single-crystal XRD analysis. DSC analysis of RIV-MAL
45
46 sample displayed a transition point at between 113-120 °C followed by endothermic peak
47
48 pertaining to cocrystal melting at ~169 °C (ΔHf is 38.8 J/g) (Figure 1a and Figure S1).
49
50
51
Subsequent to the cocrystal melting, an exothermic event for recrystallization of RIV and its
52
53 melting endothermic event at ~232 °C were observed.
54
55
56
57
58
59
60

12
ACS Paragon Plus Environment
Page 13 of 33 Molecular Pharmaceutics

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20 Figure 1. Overlay of DSC (a) and XRPD scans (b) of RIV, MAL, and RIV-MAL
21
22
23 The thermal events in the DSC scan were further verified by HSM analysis of the cocrystal
24
25 and shown as Figure S1. In HSM analysis, phase transition was observed as a change in
26
27 particle boundaries and slight movement of the particles at a temperature between 113-120
28
29
30 °C. The thermal event at ~169 °C was assigned as melting point of the cocrystal because a
31
32 phase conversion from solid-to-liquid state (an indicator of melting process for a material)
33
34 was clearly observed at this point (Figure S1). Thus, the melting point of the cocrystal (i.e.
35
36
37
169 °C) was between the melting points of the pure starting materials indicating the
38
39 formation of cocrystal phase. The characteristic peaks of RIV-MAL observed at 2Ɵ values of
40
41 11.9°, 13.6°, 15.8°, 18.8°, 19.4°, 24.0°, 27.5°, and 28.7° ± 0.2° correspond to the reported
42
43
values, confirming the successful generation of cocrystal (Figure 1b). IR frequencies of RIV,
44
45
46 MAL, and RIV-MAL are provided in Supporting Information.
47
48
49 Single Crystal Structure Analysis
50
51
52 RIV, which is 5-chloro-N-[[2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5
53
54 yl]methyl]thiophene-2-carboxamide), was crystallized in the triclinic crystal system with the
55
56 non-centrosymmetric, P1 space group. Crystal data and structure refinement parameters for
57
58
59 RIV and RIV-MAL are presented in Table S1. X-ray structure determination revealed the
60

13
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 14 of 33

1
2
3 molecular structure of RIV with a hydrogen-bonded network (Figure 2). The crystal structure
4
5
6 parameters are in a good agreement with the recently published crystal structure of RIV by
7
8 Shen and coworkers.38 Further discussion on crystallographic features of RIV can be found in
9
10 Supporting Information.
11
12
13
RIV-MAL also crystallized in the triclinic crystal system with the non-centrosymmetric, P1
14
15 space group and the structure consists of four molecules of RIV along with two molecules of
16
17 MAL (2:1 stoichiometry) (Figure 3). The antiparallel arrangement of RIV molecules as found
18
19
in the crystal structure of RIV remained intact, i.e. RIV molecules interacted with each other
20
21
22 via the similar N–H···O hydrogen bonding (N3–H3···O18, N12–H12···O3, N9–H9N···O7
23
24 and N6–H6N···O13 as shown in Table S3) as observed in the crystal structure of RIV. Thus,
25
26 the original dimeric arrangement of RIV molecules as observed in the RIV crystal structure
27
28
29 did not change upon cocrystallization with MAL. Further, the dimeric units of RIV are
30
31 engaged in O-H···O (O28–H28···O7, O25–H25A···O17, O24–H24···O12 and O22–
32
33 H22B···O2) H-bonding interactions with the MAL molecules resulting in a 2D
34
35
36
supramolecular network arrangement as shown in Figure 3. Additionally, the comparable
37
38 strength of interaction between two RIV molecules in cocrystal structure vis-à-vis RIV
39
40 structure was confirmed based on the observed similar bond length and bond angles
41
42
(directionality). However, many C–H···O type weaker intermolecular interactions were also
43
44
45 observed in the cocrystal structure (Table S4, Supporting Information). The hydrogen bond
46
47 details for RIV and RIV-MAL are provided in Tables S2 and S3, respectively. Selected bond
48
49
50
lengths and angles are given in Table S4-S5 (Supporting Information).
51
52
53
54
55
56
57
58
59
60

14
ACS Paragon Plus Environment
Page 15 of 33 Molecular Pharmaceutics

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24 Figure 2. RIV crystal structure showing the antiparallel arrangement of two RIV molecules,
25
26 interacting through a bilateral N–H···O hydrogen bonding to form a dimer in AB-AB fashion.
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
Figure 3. RIV-MAL crystal structure showing the presence of N–H···O H-bonding between RIV
53
54 molecules and O-H···O H-bonding interactions between RIV and MAL molecules.
55
56
57
58
59
60

15
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 16 of 33

1
2
3 Water Sorption Behavior (Hygroscopicity Studies)
4
5
6 The sorption-desorption profiles of RIV, MAL and RIV-MAL are shown in Figure 4. No
7
8
significant weight gain was observed in all three samples until 60% RH (<0.1% w/w).
9
10
11 However, all samples gained a significant amount of water when exposed at RH >70%. The
12
13 amount of water sorbed at 90% RH was the highest in MAL (64.8% w/w) while it was the
14
15 lowest in RIV (0.13% w/w). Hygroscopicity of RIV-MAL was observed to be intermediate
16
17
18 between RIV and MAL (6.0% w/w). A similar trend of hygroscopicity was observed when
19
20 percentage of water gained was normalized by the surface area of the respective sample
21
22 (Figure 4b). The surface area values of crystal samples measured using a Nitrogen BET
23
24
25
method (Supporting Information, Table S6). The rank order of surface area normalized
26
27 hygroscopicity of crystal samples was given to all three samples, i.e. RIV < RIV-MAL <
28
29 MAL. The overlapping of sorption and desorption profiles for RIV and RIV-MAL ruled out
30
31
the possibility of polymorphic/solid form changes during hygroscopicity studies and also
32
33
34 verified the nonexistence of crystal defects in the samples. This was further confirmed by
35
36 DSC analysis of the samples collected after DVS experiment (Supporting Information, Figure
37
38 S2-S4). Conversely, the sorption-desorption curve of MAL showed hysteresis, and 11.4%
39
40
41 water retained at the end of desorption cycle. This behavior was attributed to the deliquescent
42
43 nature of MAL.39 It is noteworthy that, the morphologies of crystals used in DVS
44
45 experiments were kept similar to that of those used in SC-XRD and face indexing
46
47
48
experiments.
49
50
51
52
53
54
55
56
57
58
59
60

16
ACS Paragon Plus Environment
Page 17 of 33 Molecular Pharmaceutics

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19 Figure 4. DVS analysis of RIV, MAL, and RIV-MAL samples (a) adsorption-desorption isotherm;
20
(b) % water gain at 90% RH/25°C (Values on bar graph show ‘Mean’ and error bar represents SD,
21
22 n=3).
23
24
25 Hydrogen Bonding Sites Available for Interaction with Water Molecules
26
27
To understand the role of surface-water interaction, it is important to identify the available
28
29
30 hydrogen bonding sites in a given crystal structure. Hydrogen bond donor/acceptor groups in
31
32 a given structure can be potential sites for hydrogen bonding with water molecules.
33
34 Nevertheless, the configuration of molecules in crystal structure affects the orientation and
35
36
37 accessibility (geometry, bond length, steric factors) of a particular H-bond donor/acceptor
38
39 and in turn the hydrogen bond formation tendency.40 Hydrogen bond is directional viz. the
40
41 bond angle, (∠X-H…Y) should be linear or near to linear (120°‒180°), therefore the H-bond
42
43
44
formation tendency of compound depends on the atomic arrangements in the crystal
45
46 structure.41 Therefore, molecular dynamics simulations were performed to better understand
47
48 the contribution of each functional group in the hydrogen bonding using the crystal structure
49
50
of RIV, MAL, and RIV-MAL. The hydrogen bonding sites available for interaction with
51
52
53 water molecules were identified in the simulations studies and are presented in Table 1. The
54
55 results show that the available hydrogen bonding sites in the cocrystal structure were equals
56
57 to sum of H-bonding sites in the individual structure of RIV and MAL.
58
59
60

17
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 18 of 33

1
2
3 Table 1. Hydrogen bonding sites available for interaction with water molecules
4
5
6 RIV MAL RIV-MAL
7 Carboxamide Carboxylic Carboxamide
8 C=O O-H (Acidic) C=O
9
C=O (Acidic)
10
11 Morpholine Morpholine
12 C=O C=O
13 Ring O Ring O
14 Oxazolidinone Oxazolidinone
15
Centre C=O Centre C=O
16
17 Central ring ‘O’ was Central ring ‘O’ was not
18 not involved. involved.
19 Carboxylic in Malonic acid
20 O-H (Acidic)
21
22
C=O (Acidic)
23 Correlating Surface Molecular Environment and Water Sorption Tendency
24
25
26 SC-XRD and face indexing are powerful techniques to understand the interactions of water
27
28
with the surface of organic solid because of two reasons: 1) Using a basic structure of the
29
30
31 solid surface one can better comprehend the properties of water as adsorbate and its
32
33 interactions with the surface, (2) powder samples are not perfect crystals and may possess
34
35 crystal defects and impurities. The water adsorption in powder samples will be influenced by
36
37
38 defects, impurities and the polycrystalline nature of the sample.12, 42 Therefore, instead of
39
40 using powdered samples, the recrystallized samples in the form of small crystals were used
41
42 for investigating molecular basis of water-sorption behavior. Face indexing and SC-XRD
43
44
45
together provided surface molecular environment (surface chemistry) of crystal samples of
46
47 RIV, MAL, and the cocrystal. Figure 5 shows photomicrographs of crystal samples of RIV,
48
49 MAL and RIV-MAL captured from face indexation analysis.
50
51
52
53
54
55
56
57
58
59
60

18
ACS Paragon Plus Environment
Page 19 of 33 Molecular Pharmaceutics

1
2
3
4
5
6
7
8
9
10
11
12
13
14 Figure 5. Images of crystal samples captured during face indexation analysis of RIV (a), MAL (b),
15 RIV-MAL (c).
16
17
18 Face indexing of RIV revealed predominant facets with their relative contributions as
19
20 follows: (011), (0-1-1), 34.8%; (010), (0-10), 28.4%; (001), (00-1), 24.7; and (01-1), (0-11),
21
22 12.1%. Visualization of RIV structure along the identified crystallographic planes helped to
23
24
25 determine exposed chemical groups onto surface of the crystal facets. Table 2 compiles the
26
27 exposed chemical groups on the crystal facets for RIV, MAL, and RIV-MAL. As shown in
28
29 Table 2, the predominant facets expose 5-chlorothiophene and a part of the aminomorpholine
30
31
ring and carbonyl (C=O) group from carboxamide. The nature of these functional groups,
32
33
34 whether hydrophilic or hydrophobic, was identified based on LP values, determined by MLP
35
36 calculations (Figure 6). The relatively higher LP value around 5-chlorothiophene
37
38 demonstrates its hydrophobic nature, while the lower LP value of the carbonyl group
39
40
41 indicates its hydrophilic nature. The carbonyl functionality in 4-aminomorpholine-3-one is
42
43 hydrophilic, whereas the rest part of the ring is hydrophobic, indicated by the higher LP
44
45 value.
46
47
48
In RIV crystal, facets namely (010), (001) and (01-1), which majorly contribute to the crystal
49
50
51 surface, exposed hydrophobic chemical groups (5-chlorothiophene and hydrophobic part of
52
53 4-aminomorpholine-3-one) (Figure 7). On the other hand, (011) facets exhibited both
54
55 hydrophilic (C=O) and hydrophobic groups (5-chlorothiophene). Summation of the
56
57
58 hydrophilic contributions (Hphi), hydrophobic contributions (Hpho), and hydrophilic plus
59
60 hydrophobic contributions (Hphi+Hpho) from all facets indicated that the RIV crystal surface

19
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 20 of 33

1
2
3 covers 65.2% hydrophobic feature, 0.0% hydrophilic feature, 34.8% both hydrophobic and
4
5
6 hydrophilic features. Thus, the lower water sorption tendency of RIV was attributed to the
7
8 presence of predominantly hydrophobic groups on the surface of crystal.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26 Figure 6. Surface representation of MLP for RIV (Lower LP sites are shaded as blue, while higher LP
27
sites are shaded as brown).
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44 Figure 7. Molecular packing diagrams illustrating surface chemistry of different facets of RIV. The
45
46 surface chemistry of (011) and its opposing (0-1-1) facets (a), and that of (010) and its opposing (0-
47
10) facets (b).
48
49
50 Unit cell parameters of MAL were in agreement with reported parameters for MAL (CSD
51
52 Reference code MALNAC02, deposition number 1209218).43 The crystal system was
53
54
55
triclinic with space group Pī (2), and cell parameters were a=5.152(1)Å, b=5.347(1)Å,
56
57 c=8.407(1)Å, α =71.42(2)°, β=76.09(2)°, γ= 85.07(2)°. MAL is a dicarboxylic acid in which
58
59 two carboxyl groups linked by a methylene-bridge. Two strong hydrogen bond acceptors
60

20
ACS Paragon Plus Environment
Page 21 of 33 Molecular Pharmaceutics

1
2
3 (C=O, carbonyl groups) and two hydrogen bond donors (‒OH, hydroxy groups) from these
4
5
6 two carboxylic functions can impart substantial hydrophilicity to MAL if they will expose
7
8 onto the crystal surface. The lower LP value around two carboxylic (‒COOH) groups of
9
10 malonic acid (blue shade) assures the hydrophilic nature (Figure 8). A small light brown
11
12
13 portion in Figure 8 represents a weak hydrophobic nature of methylene group (-CH2-) in
14
15 MAL.
16
17
18 Face indexation and crystal structure visualization using Mercury software revealed that
19
20
carbonyl and hydroxyl groups (from carboxyl group), hydrophilic groups, were
21
22
23 predominantly exposed onto (-111) and (001) facets of MAL crystal contributing ~ 57.9% of
24
25 total crystal surface area (Figure 9 and Table 2). The weakly hydrophobic methylene (‒CH)
26
27
28
group and hydrophilic carboxyl group (‒COOH) offered a mixed domain (Hphi+Hpho
29
30 contributions) onto (101) and (10-1) facets with relative abundance of ~42.1% (Figure 9 and
31
32 Table 2). In summary, the higher contribution of hydrophilic functional groups with a strong
33
34
35
intermolecular H-bond formation tendency with water molecules made MAL crystal surface
36
37 more hygroscopic. The higher strength of hydrogen bonding interaction between surface
38
39 functional groups in MAL and water molecules could be responsible for its deliquescence
40
41
nature when exposed at higher humidity. The deliquescence relative humidity of MAL at 298
42
43
44 K was reported to be 71%.39
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

21
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 22 of 33

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15 Figure 8. Surface representation of MLP for MAL (Lower LP site are shaded as blue, while higher
16 LP sites are shaded as brown).
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41 Figure 9. Molecular packing diagrams illustrating surface chemistry of different facets of MAL. The
42
surface chemistry of (001) and its opposing (00-1) facet (a), and that of (101) and its opposing (-10-1)
43
44 facets (b).
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

22
ACS Paragon Plus Environment
Page 23 of 33 Molecular Pharmaceutics

1
2
3 Table 2. Compilation of relative contribution of crystal facets, exposed functional groups on the
4
5 surface of each facet, and their nature
6
7 Facets Relative Exposed groups Nature of exposed
8
contribution of functional group
9
facet (%)
10
11 RIV
12 (011), (0-1-1) 34.8 5 -Chlorothiophene, Hydrophobic (Hpho),
13 (-C=O), Hydrophilic (Hphi),
14 Hydrophobic part of 4-Aminomorpholine-3-one Hydrophobic (Hpho)
15 (i.e. except ether oxygen and free carbonyl)
16
(010), (0-10) 28.4 5 –Chlorothiophene Hydrophobic (Hpho)
17
18 (001), (00-1) 24.7 Hydrophobic part of 4-Aminomorpholine-3-one Hydrophobic (Hpho)
19 (01-1), (0-11) 12.1 5 –Chlorothiophene Hydrophobic (Hpho)
20 MAL
21
(001), (00-1) 52.3 (-COOH) Hydrophilic (Hphi)
22
23 (101), (-10-1) 28.8 (-COOH), Hydrophilic (Hphi),
24 (-CH2) Hydrophobic (Hpho)
25 (1 0-1), (-101) 12.5 (-COOH), Hydrophilic (Hphi),
26 (-CH2) Hydrophobic (Hpho)
27 (-111), (1-1-1) 6.4 (-COOH) Hydrophilic (Hphi)
28
29 RIV-MAL
30 (001), (00-1) 57.9 5 –Chlorothiophene Hydrophobic (Hpho)
31 (101), (-10-1) 21.1 (- COOH), Hydrophobic (Hpho),
32 5 –Chlorothiophene Hydrophilic (Hphi)
33
(11-1), (-1-11) 10.9 Hydrophobic part of 4-Aminomorpholine-3-one, Hydrophobic (Hpho),
34
(- COOH) Hydrophilic (Hphi)
35
36 (111), (-1-1-1) 10.2 5 -Chlorothiophene, Hydrophobic (Hpho),
37 (- COOH), Hydrophilic (Hphi),
38 -CONH- (carboxamide) Hydrophilic (Hphi)
39
40
41
42
43 Molecular Basis of Water Sorption Behavior of the Cocrystal
44
45
Role of Relative % Contribution of Crystal Facets
46
47
48 In the crystal structure of RIV-MAL, MAL molecules were embedded in between RIV
49
50
51
molecules (Figure 10a). Visualization of different facets corresponding to Miller indices
52
53 unveiled that hydrophobic group, 5-chlorothiophene was exposed onto major (001) facet of
54
55 the cocrystal contributing 57.9% of the total surface area. Interestingly, a strongly hydrophilic
56
57
(carboxyl from MAL) as well as hydrophobic (5-chlorothiophene) groups were exposed onto
58
59
60

23
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 24 of 33

1
2
3 (101) and (111) facets accounting 42.1% relative contributions to entire crystal surface
4
5
6 (Figure 10b, Table 2).
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26 Figure 10. Molecular packing diagrams illustrating surface chemistry of different facets of RIV-
27
28 MAL. The surface chemistry of (001) and its opposing (00-1) facet (a), and that of (101) and its
29
opposing (-10-1) facets (b). Insert and arrows indicate the position of MAL molecules.
30
31
32 As represented in Figure 11 pie-diagram, cocrystallization of RIV with MAL imparted
33
34 hydrophilic groups onto its crystal surface as the ‘Hphi+Hpho’ character was found to have
35
36
37
increased from 34.8% in RIV to 42.1% in RIV-MAL. At the same time, the hydrophobic
38
39 contributions decreased from 65.2% in RIV to 57.9% in RIV-MAL. The increased
40
41 (Hphi+Hpho) character and the decreased hydrophobicity could be responsible for the higher
42
43
amount of water sorption by the cocrystal in comparison with RIV. However, the amount of
44
45
46 water gained per unit surface area by RIV-MAL cocrystal was around 39 times higher as
47
48 compared to RIV. The reason for the significant change in sorption tendency of RIV-MAL,
49
50 despite only small changes in contributions of ‘Hphi+Hpho’ (from 34.8% in RIV to 42.1% in
51
52
53 RIV-MAL), was further examined. The further investigation was carried out by comparing
54
55 the exposed hydrophilic groups in RIV-MAL and RIV for the strength of hydrogen bonding
56
57 interaction between the surface-exposed hydrophilic groups and the water molecule.
58
59
60

24
ACS Paragon Plus Environment
Page 25 of 33 Molecular Pharmaceutics

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27 Figure 11. Pie diagram showing hydrophilic (Hphi), hydrophobic (Hpho) and hydrophilic plus
28
29 hydrophilic (Hphi+Hpho) contributions onto the crystal surface of MAL, RIV, and RIV-MAL.
30 Cocrystallization of RIV with MAL led to an increase in ‘Hphi+Hpho’ surface contribution from 34.8
31
32 to 42.1% while a decrease in Hpho surface contribution from 65.2 to 57.9%.
33
34 Impact of Strength of Hydrogen Bonding Interactions
35
36
37 At molecular level, adsorption process involves formation of a surface monolayer of water
38
39 molecules. At given temperature and RH, equilibrium exists between adsorbed and desorbed
40
41
42 molecules on a crystal surface. Adsorption process becomes favorable when water molecules
43
44 form a relatively strong hydrogen bonding interactions with exposed chemical groups on
45
46 crystal surface.12, 42 The stabilization of monolayer of water molecules on crystal surface
47
48
49 triggers multilayer (up to three layers) formation, and subsequently higher amount of water
50
51 sorption can be seen. Thus, the presence of surface chemical groups that have strong
52
53 hydrogen bonding interaction with water molecules, may favor the water sorption tendency
54
55
of crystalline solid as compared to those with weak hydrogen bonding interactions. Thus, the
56
57
58 strength of hydrogen bonding interaction between exposed chemical groups on crystal
59
60 surface and water molecules would be more important in the cases where different amounts

25
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 26 of 33

1
2
3 of water sections has been observed in two crystal systems, despite having similar
4
5
6 ‘Hphi+Hpho’ contributions on their crystal surfaces.
7
8
9 ‘Hphi+Hpho’ nature imparted to RIV was due to 5-chlorothiophene and carbonyl (C=O)
10
11 groups. Similarly, ‘Hphi+Hpho’ in RIV-MAL was due to the presence of 5-chlorothiophene
12
13
and carboxyl (‒COOH) groups. In both cases, 5-chlorothiophene is common and hence they
14
15
16 had similar interactions with water molecules. A carboxyl group (‒COOH) from MAL in
17
18 RIV-MAL consists of both H-bond donor (hydroxyl, ‒OH group) and H-bond acceptor
19
20
21 (carbonyl, C=O group). In contrast, only a hydrogen bond acceptor (C=O) was exposed in the
22
23 case of RIV. DFT calculations were performed to quantify the strength of hydrogen bonding
24
25 between exposed functional groups on the crystal surface and water molecule. The
26
27
comparative analysis of the strength of hydrogen bonding interaction for C=O in RIV vis-à-
28
29
30 vis C=O and –OH (from MAL) in RIV-MAL was carried out. The hydrogen bonding
31
32 interaction energies (∆E) for RIV-H2O and MAL-H2O complexes (dual-bonded) were found
33
34 to be -5.1 and -10.2 kcal/mol, respectively. In RIV-MAL, the interaction energy for MAL-
35
36
37 H2O complex (dual-bonded) was found to have 5.1 kcal/mol lower than the interaction
38
39 energy of RIV-H2O, depicting the stronger H-bonding in the cocrystal (Figure 12). The
40
41 crystal surface of RIV-MAL contains both carbonyl and hydroxy groups of MAL, which
42
43
44 form bilateral H-bonds (dual H-bond) with a water molecule and yields the more stable
45
46 complex as compared to carbonyl groups of RIV (Figure 12a and b). Moreover, even the
47
48 carbonyl group in MAL forms relatively stronger hydrogen bond (∆E= -6.1 kcal/mol) in
49
50
comparison with the exposed carbonyl groups in RIV (∆E= -5.1 kcal/mol) (Figure 12c). The
51
52
53 formation of a strong H-bond between the carboxyl group (from acid) and another hydroxy
54
55 group (from water) has been well reported in the literature,41, 44 which further supports the
56
57 findings of DFT studies. Collectively, the relative % contributions of ‘Hphi+Hpho’ domain
58
59
60

26
ACS Paragon Plus Environment
Page 27 of 33 Molecular Pharmaceutics

1
2
3 and the strength of hydrogen bonding interaction explained the reason for the relatively
4
5
6 greater amount of water gained by RIV-MAL as compared to RIV.
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28 Figure 12. The hydrogen bonding interaction energy for interaction of water with (a) carbonyl of
29
30 RIV, (b) carbonyl and hydroxy group of MAL and (c) only carbonyl of MAL.
31
32 The crystal packing density can be another important factor in the cases where hydrate
33
34
formation is evident during sorption-desorption studies. The crystal packing densities were
35
36
37 1.554, 1.621 and 1.548 g/cm2 for RIV, MAL, and RIV-MAL, respectively. The crystal
38
39 structure with inefficient packing and large void allows easy penetration of water molecules
40
41 inside crystal lattice to form crystal hydrate.1, 45, 46 The absence of hydrate formation in RIV-
42
43
44 MAL indicated no role of crystal packing density.
45
46
47 Summary of the approach adopted for investigating the molecular basis of water sorption
48
49 behavior of the cocrystal is presented in Scheme 1. This scheme also captures a
50
51 comprehensive summary of this work. We believe that this systematic approach shall be
52
53
54 utilized to comprehensively understand the mechanistic basis of water-sorption behavior
55
56 using a large set of single and multi-components crystalline organic solids.
57
58
59
60

27
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 28 of 33

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28 Scheme 1. Approach adopted to understand the molecular basis of water sorption behavior of the
29
30 cocrystal
31
32
33
CONCLUSIONS
34
35 The present study revealed that the extent of water sorption by RIV-MAL is governed by the
36
37 nature of the surface chemical groups exposed, their relative contributions onto the crystal
38
39 surface, and the strength of hydrogen bonding between the exposed chemical groups and
40
41
42 water molecules. Remarkably, the strength of hydrogen bonding has a profound impact on
43
44 the hygroscopicity of the cocrystal as the significantly higher water sorption (~39 times) was
45
46 observed in the cocrystal than RIV, despite only small changes in the surface contribution of
47
48
‘Hphi+Hpho’ domain. In a broad sense, the study highlighted that the moisture sorption
49
50
51 property of single-component (RIV and MAL) and multi-component (RIV-MAL) systems
52
53 depends on the surface chemical environment of a crystal and not the entire crystal structure,
54
55 provided there is no hydrate formation. In the framework of crystal engineering and structure-
56
57
58 property correlations, the present understandings have implications on designing materials
59
60 with desired moisture-sorption property.

28
ACS Paragon Plus Environment
Page 29 of 33 Molecular Pharmaceutics

1
2
3 SUPPORTING INFORMATION
4
5
6
Supporting information provided include: HSM analysis of RIV-MAL, IR frequencies of
7
8 RIV, MAL and the cocrystal, Crystal structure description of RIV, Specific surface area of
9
10 crystal samples, DSC heating curves of all three samples collected after DVS experiments,
11
12
Original (black and white) crystal image of RIV-MAL, Crystal size of samples used for face
13
14
15 indexing, List of coordinates and the absolute energies of the optimized geometry in DFT
16
17 calculations, Selected bond length and bond angle, and Details of hydrogen bond geometry
18
19 for RIV and RIV-MAL.
20
21
22
23 ACCESSION CODES
24
25 CCDC 1854617-1854618 contain the supplementary crystallographic data for this paper.
26
27 These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by
28
29 emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic
30
31
32 Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
33
34
35 ACKNOWLEDGMENTS
36
37 We are grateful to Ikjot Sodhi for her help in MLP calculations, and Sneha Sheokand for her
38
39
valuable suggestions in DVS study. Authors also would like to thank Gunjan Kohli, Jyoti
40
41
42 Garg, Samarth D. Thakore and Sandeep S. Zode for insightful discussions (all from NIPER,
43
44 SAS Nagar). Dnyaneshwar acknowledges Department of Pharmaceuticals, Ministry of
45
46 Chemicals and Fertilizers, Government of India for the financial support.
47
48
49
50 REFERENCES
51
52 1. Reutzel-Edens, S. M.; Newman, A. W., The physical characterization of hygroscopicity in
53 pharmaceutical solids. In Polymorphism in the Pharmaceutical Industry, Wiley-VCH, Weinheim:
54 2006; pp 235-258.
55 2. Newman, A. W.; Reutzel-Edens, S. M.; Zografi, G. Characterization of the “hygroscopic”
56 properties of active pharmaceutical ingredients. Journal of Pharmaceutical Sciences, 2008, 97,
57 (3), 1047-1059.
58 3. Callahan, J.; Cleary, G.; Elefant, M., et al. Equilibrium moisture content of pharmaceutical
59
excipients. Drug Development and Industrial Pharmacy, 1982, 8, (3), 355-369.
60

29
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 30 of 33

1
2
3 4. Ahlneck, C.; Zografi, G. The molecular basis of moisture effects on the physical and chemical
4 stability of drugs in the solid state. International Journal of Pharmaceutics, 1990, 62, (2-3), 87-
5 95.
6
7 5. Cleaver, J.; Karatzas, G.; Louis, S., et al. Moisture-induced caking of boric acid powder. Powder
8 Technology, 2004, 146, (1), 93-101.
9 6. Rohrs, B. R.; Thamann, T. J.; Gao, P., et al. Tablet dissolution affected by a moisture mediated
10 solid-state interaction between drug and disintegrant. Pharmaceutical Research, 1999, 16, (12),
11 1850-1856.
12 7. Sun, C. C. Mechanism of moisture induced variations in true density and compaction properties
13 of microcrystalline cellulose. International Journal of Pharmaceutics, 2008, 346, (1), 93-101.
14
8. Balbach, S.; Korn, C. Pharmaceutical evaluation of early development candidates “the 100 mg-
15
16
approach”. International Journal of Pharmaceutics, 2004, 275, (1-2), 1-12.
17 9. Newman, A.; Zografi, G. An Examination of Water Vapor Sorption by Multi-Component
18 Crystalline and Amorphous Solids and Its Effects on their Solid-State Properties. Journal of
19 Pharmaceutical Sciences, 2018.
20 10. Sheokand, S.; Modi, S. R.; Bansal, A. K. Dynamic vapor sorption as a tool for characterization
21 and quantification of amorphous content in predominantly crystalline materials. Journal of
22 Pharmaceutical Sciences, 2014, 103, (11), 3364-3376.
23
11. Byrn, S. R.; Zografi, G.; Chen, X. S., Solid-state properties of pharmaceutical materials. In
24
Chapter 15 Hygroscopic Properties of Solids, First ed.; John Wiley & Sons, Inc.: NJ, USA, 2017;
25
26
pp 213-230.
27 12. Zografi, G. States of water associated with solids. Drug Development and Industrial Pharmacy,
28 1988, 14, (14), 1905-1926.
29 13. Heng, J. Y.; Bismarck, A.; Williams, D. R. Anisotropic surface chemistry of crystalline
30 pharmaceutical solids. AAPS PharmSciTech, 2006, 7, (4), E12-E20.
31 14. Heng, J. Y.; Bismarck, A.; Lee, A. F., et al. Anisotropic surface energetics and wettability of
32 macroscopic form I paracetamol crystals. Langmuir, 2006, 22, (6), 2760-2769.
33
34 15. Heng, J. Y.; Bismarck, A.; Lee, A. F., et al. Anisotropic surface chemistry of aspirin crystals.
35 Journal of Pharmaceutical Sciences, 2007, 96, (8), 2134-2144.
36 16. Jain, T.; Sheokand, S.; Modi, S. R., et al. Effect of differential surface anisotropy on performance
37 of two plate shaped crystals of aspirin form I. European Journal of Pharmaceutical Sciences,
38 2017, 99, 318-327.
39 17. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Pharmaceutical cocrystallization: Engineering a
40 remedy for caffeine hydration. Crystal Growth & Design, 2005, 5, (3), 1013-1021.
41
18. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Physical stability enhancement of theophylline via
42
cocrystallization. International Journal of Pharmaceutics, 2006, 320, (1), 114-123.
43
44 19. Vogt, F. G.; Dell'Orco, P. C.; Diederich, A. M., et al. A study of variable hydration states in
45 topotecan hydrochloride. Journal of Pharmaceutical and Biomedical Analysis, 2006, 40, (5),
46 1080-1088.
47 20. Schultheiss, N.; Newman, A. Pharmaceutical cocrystals and their physicochemical properties.
48 Crystal Growth and Design, 2009, 9, (6), 2950-2967.
49 21. Cherukuvada, S.; Babu, N. J.; Nangia, A. Nitrofurantoin–p-aminobenzoic acid cocrystal:
50 Hydration stability and dissolution rate studies Journal of Pharmaceutical Sciences, 2011, 100,
51
(8), 3233-3244.
52
53 22. Wang, Z.-Z.; Chen, J.-M.; Lu, T.-B. Enhancing the hygroscopic stability of S-oxiracetam via
54 pharmaceutical cocrystals. Crystal Growth and Design, 2012, 12, (9), 4562-4566.
55 23. Bolla, G.; Nangia, A. Pharmaceutical cocrystals: Walking the talk. Chemical Communications,
56 2016, 52, (54), 8342-8360.
57 24. Kale, D. P.; Zode, S. S.; Bansal, A. K. Challenges in translational development of pharmaceutical
58 cocrystals. Journal of Pharmaceutical Sciences, 2017, 106, (2), 457-470.
59
60

30
ACS Paragon Plus Environment
Page 31 of 33 Molecular Pharmaceutics

1
2
3 25. Shinozaki, T.; Ono, M.; Higashi, K., et al. A novel drug–drug co-crystal of levofloxacin and
4 metacetamol: Reduced hygroscopicity and improved photostability of levofloxacin. Journal of
5 Pharmaceutical Sciences, 2019, In Press. Doi.org/10.1016/j.xphs.2019.02.014.
6
7 26. SMART (V 5.628), SAINT (V 6.45a), XPREP, SHELXTL; Bruker AXS Inc., Madison,
8 Wisconsin, USA, 2004.
9 27. Sheldrick, G. M.; Siemens area detector absorption correction program, University of Göttingen,
10 Göttingen, Germany, 2004.
11 28. Altomare, A.; Cascarano, G.; Giacovazzo, C., et al. Completion and refinement of crystal
12 structures with SIR92. Journal of Applied Crystallography, 1993, 26, (3), 343-350.
13
29. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallographica Section C:
14
Structural Chemistry, 2015, 71, (1), 3-8.
15
16 30. Farrugia, L. J. WinGX- A Windows program for crystal structure analysis Journal of Applied
17 Crystallography, 2012, 45, (4), 849-854.
18 31. Bowers, K. J.; Chow, D. E.; Xu, H., et al. In Scalable algorithms for molecular dynamics
19 simulations on commodity clusters, SC 2006 conference, proceedings of the ACM/IEEE, 2006;
20 IEEE: pp 43-43.
21 32. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and testing of the OPLS all-
22 atom force field on conformational energetics and properties of organic liquids. Journal of the
23
American Chemical Society, 1996, 118, (45), 11225-11236.
24
25 33. Cornell, W. D.; Cieplak, P.; Bayly, C. I., et al. A second generation force field for the simulation
26 of proteins, nucleic acids, and organic molecules. Journal of the American Chemical Society,
27 1995, 117, (19), 5179-5197.
28 34. Hao, M.-H. Theoretical calculation of hydrogen-bonding strength for drug molecules. Journal of
29 Chemical Theory and Computation, 2006, 2, (3), 863-872.
30 35. Gaussian 09, Revision B.01. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A.
31 Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M.
32 Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada,
33
M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H.
34
Nakai, T. Vreven, J. A. Montgomery, Jr. J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E.
35
Brothers, K. N. Kudin, V. N. Staroverov, T. Keith, R. Kobayashi, J. Normand, K. Raghavachari,
36
37
A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J.
38 E. Knox, J. B.Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O.
39 Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W.Ochterski, R. L. Martin, K. Morokuma, V. G.
40 Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J.
41 B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, Gaussian, Inc., Wallingford CT. 2010.
42 36. Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into
43 a functional of the electron density. Physical Review B, 1988, 37, (2), 785-789.
44 37. Enantia, S. L. Novel crystalline forms of rivaroxaban and processes for their preparation. EP
45 2573084A1. 2013.
46
47
38. Shen, J.; Tang, G.-P.; Hu, X.-R. Crystal structure of (S)-5-chloro-N-({2-oxo-3-[4-(3-
48 oxomorpholin-4-yl) phenyl] oxazolidin-5-yl} methyl) thiophene-2-carboxamide. Acta
49 Crystallographica Section E: Crystallographic Communications, 2018, 74, (1), 51-54.
50 39. Beyer, K. D.; Schroeder, J. R.; Kissinger, J. A. Temperature-dependent deliquescence relative
51 humidities and water activities using humidity controlled thermogravimetric analysis with
52 application to malonic acid. The Journal of Physical Chemistry A, 2014, 118, (13), 2488-2497.
53 40. Desiraju, G. R.; Vittal, J. J.; Ramanan, A., Crystal engineering: a textbook. World Scientific
54 Publishing Co.: 2011.
55
41. Desiraju, G. R.; Steiner, T., The weak hydrogen bond: in structural chemistry and biology.
56
57
Oxford University Press, New York, USA: 2001.
58 42. Henderson, M. A. The interaction of water with solid surfaces: fundamental aspects revisited.
59 Surface Science Reports, 2002, 46, (1-8), 1-308.
60

31
ACS Paragon Plus Environment
Molecular Pharmaceutics Page 32 of 33

1
2
3 43. Jagannathan, N.; Rajan, S.; Subramanian, E. Refinement of the crystal structure of malonic acid,
4 C 3 H 4 O 4. Journal of Chemical Crystallography, 1994, 24, (1), 75-78.
5
6
44. Gilli, G.; Gilli, P., The nature of the hydrogen bond: outline of a comprehensive hydrogen bond
7 theory. Oxford University Press: 2009.
8 45. Desiraju, G. R. Hydration in organic crystals: prediction from molecular structure. Journal of the
9 Chemical Society, Chemical Communications, 1991, (6), 426-428.
10 46. Mizoguchi, R.; Uekusa, H. Elucidating the Dehydration Mechanism of Ondansetron
11 Hydrochloride Dihydrate with a Crystal Structure. Crystal Growth & Design, 2018, 18, (10),
12 6142-6149.
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

32
ACS Paragon Plus Environment
Page 33 of 33 Molecular Pharmaceutics

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23 250x113mm (150 x 150 DPI)
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 ACS Paragon Plus Environment

Вам также может понравиться